Lab Automation Market worth USD 5.5 billion by 2033 - Exclusive Report by Future Market Insights, Inc.
The growth in the laboratory automation systems market is due to increased demand for microbiology testing and standardization of sample-collection devices for microbiology. North America region is expected to hold the largest laboratory automation systems market share.
NEWARK, Del, Feb. 09, 2023 (GLOBE NEWSWIRE) -- During the forecast period, the lab automation market size is expected to register a CAGR of 10.1%. The market is anticipated to grow from a valuation of USD 2.1 billion in 2023 to USD 5.5 billion by 2033.
Research and Innovations Aid Market Growth
Pharmaceutical research is in constant demand, which protects the market. In the pharmaceutical and healthcare industries, automation is also a major trend right now. Even in emerging countries, both of these are assisting the market. In order to meet the unique needs of lab automation users, additional important companies are eager to offer products that are industry-specific.
Get the Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-394
Fertile Ground for Market Growth
To maintain the rapid product uptake, key players must work more on product development. This era is anticipated to be profitable for market growth due to factors like rising diagnostic rates internationally. Recent trends show that major businesses are combining their resources through mergers and acquisitions to strengthen their market positions.
Technological Innovations Emerge as an Integral Part of Market Growth
Long-term market potential for lab automation are predicted to result from end-user demand for high-end, sophisticated lab automation technologies. The development of lab robotics technology, which is still in its infancy, is one factor that is anticipated to support market expansion. For lab automation technology to be appealing to pharmaceutical and healthcare enterprises of various sizes, it must be exceedingly frictionless and effective.
Can Market Key Players Rise Above the Hurdles of High Cost?
Adoption and maintenance of lab automation equipment currently amount to considerable costs. Hence, small and medium enterprises tend to shy away from the adoption of lab automation tools. The major consumer base of key players currently consists of mega-corporations, that are willing to spend millions for high-end efficient lab automation systems. By developing affordable products, key players can easily break into the small and medium enterprises segment. Once the large organization segment reaches saturation, key players will naturally have to turn to smaller enterprises to sustain market growth.
Talk with Research Expert: https://www.futuremarketinsights.com/ask-question/rep-gb-394
Recent Market Developments:
In March 2022, Beckman Coulter Life Sciences introduced the CellMek SPS. The product enables seamless manual sample preparation. It has aided in easing data management bottlenecks in clinical flow cytometry. It is a fully automated sample preparation system (SPS) that would aid laboratories in vastly expanding their current production capabilities.
In April 2022, Strateos Inc. launched an integrated solution for small molecule discovery programs that aid in automating the DMTA cycles.
In March 2022, Biosero released the Green Button Go software suite in March 2022. It comes with advanced features to assist customers in yielding better control over laboratory systems.
In March 2022, Thermo Fisher Scientific and Hamilton Company jointly launched an advanced product. It is their forensic laboratory-qualified automated nucleic acid extraction platform.
Leading companies operating in the lab automation market are Abbott Laboratories, Agilent Technologies, Perkin Elmer, Inc, Thermo Fisher Scientific, Inc, Siemens Healthcare, Danaher Corporation, Becton, Dickinson and Company, Transcriptic, Inc. among others.
Buy Complete Report: https://www.futuremarketinsights.com/checkout/394
By Component Type:
Momentum Integration Software
Life Sciences Research and Development
By End User:
Hospitals and Diagnostic Centers
Contract Research Organizations (CROs)
Table of Content:
1. Executive Summary | Lab Automation Market
1.1. Global Market Outlook
1.2. Demand to side Trends
1.3. Supply to side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope/Limitations
3. Market Background
3.1. Market Dynamics
3.1.4. Trends TOC Continue..
Complete TOC with Report Preview: https://www.futuremarketinsights.com/reports/lab-automation-market
Have a Look at Related Research Reports of Healthcare Domain:
Biodefense Market Size - The global biodefense market size was valued at US$ 16.31 billion in the year 2023 and is estimated to reach a revised size of US$ 32.99 billion by 2033.
Erythema Treatment Market Growth - The global erythema treatment market is expected to garner a market value of US$ 184.41 Million in 2023 and is expected to accumulate a market value of US$ 315 Million by registering a CAGR of 5.5% in the forecast period 2023 to 2033.
Epidemic Keratoconjunctivitis Treatment Market Trends - The global epidemic keratoconjunctivitis treatment market is expected to garner a market value of US$ 500 million in 2023 and is expected to accumulate a market value of US$ 814.45 million by registering a CAGR of 5% in the forecast period 2023 to 2033.
Softgel Capsules Market Demand - The global softgel capsules market is expected to enjoy a valuation of US$ 1.1 Billion by the end of the year 2022, and further expand at a CAGR of 6.0% to reach a valuation of ~US$ 1.9 Billion by the year 2032.
Gastrointestinal Stent Market Forecast - The global gastrointestinal stent market holds a valuation of US$ 455.44 Million by the end of the year 2022. Throughout the forecast period of 2023 to 2033.
About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
LinkedIn | Twitter | Blogs | YouTube